Longitudinal monitoring of latent and active human cytomegalovirus infections in peripheral blood of heart transplant recipients by single-tube nested RT-PCR

PCR is a sensitive diagnostic tool for the detection of human cytomegalovirus (HCMV) DNA in the peripheral blood of immunosuppressed transplant recipients. However, its specificity as a prognostic marker for clinical disease is unclassified, because infections considered to be latent may be detected...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Microbiological research 1996-12, Vol.151 (4), p.343-349
Hauptverfasser: Wolff, Dietmar, Skourtopoulos, Menelaos, Hörnschemeyer, Dirk, Wolff, Carsten, Körner, Michael, Körfer, Reiner, Kleesiek, Knut
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 349
container_issue 4
container_start_page 343
container_title Microbiological research
container_volume 151
creator Wolff, Dietmar
Skourtopoulos, Menelaos
Hörnschemeyer, Dirk
Wolff, Carsten
Körner, Michael
Körfer, Reiner
Kleesiek, Knut
description PCR is a sensitive diagnostic tool for the detection of human cytomegalovirus (HCMV) DNA in the peripheral blood of immunosuppressed transplant recipients. However, its specificity as a prognostic marker for clinical disease is unclassified, because infections considered to be latent may be detected by this method. In order to diagnose active viral infections, we used reverse transcription-PCR (RT-PCR) to identify HCMV mRNA in blood. We developed a single-tube nested RT-PCR with preformed PCR mixes embedded in a trehalose matrix. Blood samples of 48 heart transplant recipients were investigated for HCMV DNA. 8 patients detected to be HCMV DNA positive after transplantation were investigated in longitudinal monitoring for at least 6 months. HCMV mRNA was found in 5 patients who developed HCMV related symptoms during the period of RNA detection. There was no clear relation between the onset of DNA detection and the first demonstration of mRNA. In 2 patients HCMV DNA could be detected 74 and 81 days before the appearance of mRNA, suggesting long persistence until active infection is started. In 3 patients HCMV mRNA disappeared during or immediately after the end of ganciclovir therapy. In contrast, HCMV DNA was detectable continuously for prolonged periods after therapy, indicating that the persistance of HCMV DNA is not influenced by ganciclovir treatment. In summary, HCMV mRNA detection seems to be a reliable early marker for the differentiation of persistent and active HCMV infections in immunosuppressed patients. Our data show that viral mRNA detection is probably a better predictor of the effectiveness of antiviral therapy than viral DNA detection.
doi_str_mv 10.1016/S0944-5013(96)80002-4
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_78676377</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0944501396800024</els_id><sourcerecordid>78676377</sourcerecordid><originalsourceid>FETCH-LOGICAL-c389t-8f492070882a9d7ca01c4592f148972466641deac1905b19673fc4367456504f3</originalsourceid><addsrcrecordid>eNqFkVGL1DAUhYMo6-zqT1jIg4g-VJM0TZonWQZdhQFlXZ9Dmt7ORNqkJunA_Bj_q5mdYV59SuB-99zDOQjdUvKBEio-_iSK86ohtH6nxPuWEMIq_gytqKBtRQSrn6PVBXmJrlP6TQjlqmVX6EoRxphSK_R3E_zW5aV33ox4Ct7lEJ3f4jDg0WTwGRvfY2Oz2wPeLZPx2B5ymGBrxrB3cUnY-QHKPPjjF88Q3byDWOS6MYT-qLQDEzPO0fg0j6ZoRrBudkU94e6AUzk4QpWXDrCHlKHHD4_Vj_XDK_RiMGOC1-f3Bv368vlx_bXafL__tr7bVLZuVa7agStGJGlbZlQvrSHU8kaxgfJWScaFEJz2YCxVpOmoErIeLK-F5I1oCB_qG_T2pDvH8GcpDvTkkoWxeIWwJC1bIUUtZQGbE2hjSCnCoOfoJhMPmhJ9rEU_1aKPmWsl9FMtmpe92_OBpZugv2ydeyjzN-e5SdaMQ0nKunTBWMMlqWnBPp0wKGHsHUSdbEnRQu9Koln3wf3HyD-E36t8</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>78676377</pqid></control><display><type>article</type><title>Longitudinal monitoring of latent and active human cytomegalovirus infections in peripheral blood of heart transplant recipients by single-tube nested RT-PCR</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Wolff, Dietmar ; Skourtopoulos, Menelaos ; Hörnschemeyer, Dirk ; Wolff, Carsten ; Körner, Michael ; Körfer, Reiner ; Kleesiek, Knut</creator><creatorcontrib>Wolff, Dietmar ; Skourtopoulos, Menelaos ; Hörnschemeyer, Dirk ; Wolff, Carsten ; Körner, Michael ; Körfer, Reiner ; Kleesiek, Knut</creatorcontrib><description>PCR is a sensitive diagnostic tool for the detection of human cytomegalovirus (HCMV) DNA in the peripheral blood of immunosuppressed transplant recipients. However, its specificity as a prognostic marker for clinical disease is unclassified, because infections considered to be latent may be detected by this method. In order to diagnose active viral infections, we used reverse transcription-PCR (RT-PCR) to identify HCMV mRNA in blood. We developed a single-tube nested RT-PCR with preformed PCR mixes embedded in a trehalose matrix. Blood samples of 48 heart transplant recipients were investigated for HCMV DNA. 8 patients detected to be HCMV DNA positive after transplantation were investigated in longitudinal monitoring for at least 6 months. HCMV mRNA was found in 5 patients who developed HCMV related symptoms during the period of RNA detection. There was no clear relation between the onset of DNA detection and the first demonstration of mRNA. In 2 patients HCMV DNA could be detected 74 and 81 days before the appearance of mRNA, suggesting long persistence until active infection is started. In 3 patients HCMV mRNA disappeared during or immediately after the end of ganciclovir therapy. In contrast, HCMV DNA was detectable continuously for prolonged periods after therapy, indicating that the persistance of HCMV DNA is not influenced by ganciclovir treatment. In summary, HCMV mRNA detection seems to be a reliable early marker for the differentiation of persistent and active HCMV infections in immunosuppressed patients. Our data show that viral mRNA detection is probably a better predictor of the effectiveness of antiviral therapy than viral DNA detection.</description><identifier>ISSN: 0944-5013</identifier><identifier>EISSN: 1618-0623</identifier><identifier>DOI: 10.1016/S0944-5013(96)80002-4</identifier><identifier>PMID: 9022299</identifier><language>eng</language><publisher>Basingstoke: Elsevier GmbH</publisher><subject>Antibodies, Viral - immunology ; antiviral therapy ; Biological and medical sciences ; Cytomegalovirus - immunology ; Cytomegalovirus - isolation &amp; purification ; Cytomegalovirus - physiology ; Cytomegalovirus Infections - blood ; Cytomegalovirus Infections - complications ; Cytomegalovirus Infections - diagnosis ; DNA Primers - genetics ; DNA, Complementary - biosynthesis ; DNA, Viral - isolation &amp; purification ; early diagnosis ; ganciclovir ; Ganciclovir - therapeutic use ; Genes, Viral ; Heart Transplantation - adverse effects ; Human viral diseases ; Humans ; Immunocompromised Host ; Immunosuppression ; Infectious diseases ; Longitudinal Studies ; Medical sciences ; patient management ; Polymerase Chain Reaction - methods ; RNA, Viral - isolation &amp; purification ; Sensitivity and Specificity ; Time Factors ; trehalose ; Viral diseases ; Viral diseases of the lymphoid tissue and the blood. Aids ; Virus Latency - drug effects</subject><ispartof>Microbiological research, 1996-12, Vol.151 (4), p.343-349</ispartof><rights>1996 Gustav Fischer Verlag Jena GmbH</rights><rights>1997 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c389t-8f492070882a9d7ca01c4592f148972466641deac1905b19673fc4367456504f3</citedby><cites>FETCH-LOGICAL-c389t-8f492070882a9d7ca01c4592f148972466641deac1905b19673fc4367456504f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0944501396800024$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=2547031$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9022299$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Wolff, Dietmar</creatorcontrib><creatorcontrib>Skourtopoulos, Menelaos</creatorcontrib><creatorcontrib>Hörnschemeyer, Dirk</creatorcontrib><creatorcontrib>Wolff, Carsten</creatorcontrib><creatorcontrib>Körner, Michael</creatorcontrib><creatorcontrib>Körfer, Reiner</creatorcontrib><creatorcontrib>Kleesiek, Knut</creatorcontrib><title>Longitudinal monitoring of latent and active human cytomegalovirus infections in peripheral blood of heart transplant recipients by single-tube nested RT-PCR</title><title>Microbiological research</title><addtitle>Microbiol Res</addtitle><description>PCR is a sensitive diagnostic tool for the detection of human cytomegalovirus (HCMV) DNA in the peripheral blood of immunosuppressed transplant recipients. However, its specificity as a prognostic marker for clinical disease is unclassified, because infections considered to be latent may be detected by this method. In order to diagnose active viral infections, we used reverse transcription-PCR (RT-PCR) to identify HCMV mRNA in blood. We developed a single-tube nested RT-PCR with preformed PCR mixes embedded in a trehalose matrix. Blood samples of 48 heart transplant recipients were investigated for HCMV DNA. 8 patients detected to be HCMV DNA positive after transplantation were investigated in longitudinal monitoring for at least 6 months. HCMV mRNA was found in 5 patients who developed HCMV related symptoms during the period of RNA detection. There was no clear relation between the onset of DNA detection and the first demonstration of mRNA. In 2 patients HCMV DNA could be detected 74 and 81 days before the appearance of mRNA, suggesting long persistence until active infection is started. In 3 patients HCMV mRNA disappeared during or immediately after the end of ganciclovir therapy. In contrast, HCMV DNA was detectable continuously for prolonged periods after therapy, indicating that the persistance of HCMV DNA is not influenced by ganciclovir treatment. In summary, HCMV mRNA detection seems to be a reliable early marker for the differentiation of persistent and active HCMV infections in immunosuppressed patients. Our data show that viral mRNA detection is probably a better predictor of the effectiveness of antiviral therapy than viral DNA detection.</description><subject>Antibodies, Viral - immunology</subject><subject>antiviral therapy</subject><subject>Biological and medical sciences</subject><subject>Cytomegalovirus - immunology</subject><subject>Cytomegalovirus - isolation &amp; purification</subject><subject>Cytomegalovirus - physiology</subject><subject>Cytomegalovirus Infections - blood</subject><subject>Cytomegalovirus Infections - complications</subject><subject>Cytomegalovirus Infections - diagnosis</subject><subject>DNA Primers - genetics</subject><subject>DNA, Complementary - biosynthesis</subject><subject>DNA, Viral - isolation &amp; purification</subject><subject>early diagnosis</subject><subject>ganciclovir</subject><subject>Ganciclovir - therapeutic use</subject><subject>Genes, Viral</subject><subject>Heart Transplantation - adverse effects</subject><subject>Human viral diseases</subject><subject>Humans</subject><subject>Immunocompromised Host</subject><subject>Immunosuppression</subject><subject>Infectious diseases</subject><subject>Longitudinal Studies</subject><subject>Medical sciences</subject><subject>patient management</subject><subject>Polymerase Chain Reaction - methods</subject><subject>RNA, Viral - isolation &amp; purification</subject><subject>Sensitivity and Specificity</subject><subject>Time Factors</subject><subject>trehalose</subject><subject>Viral diseases</subject><subject>Viral diseases of the lymphoid tissue and the blood. Aids</subject><subject>Virus Latency - drug effects</subject><issn>0944-5013</issn><issn>1618-0623</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1996</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkVGL1DAUhYMo6-zqT1jIg4g-VJM0TZonWQZdhQFlXZ9Dmt7ORNqkJunA_Bj_q5mdYV59SuB-99zDOQjdUvKBEio-_iSK86ohtH6nxPuWEMIq_gytqKBtRQSrn6PVBXmJrlP6TQjlqmVX6EoRxphSK_R3E_zW5aV33ox4Ct7lEJ3f4jDg0WTwGRvfY2Oz2wPeLZPx2B5ymGBrxrB3cUnY-QHKPPjjF88Q3byDWOS6MYT-qLQDEzPO0fg0j6ZoRrBudkU94e6AUzk4QpWXDrCHlKHHD4_Vj_XDK_RiMGOC1-f3Bv368vlx_bXafL__tr7bVLZuVa7agStGJGlbZlQvrSHU8kaxgfJWScaFEJz2YCxVpOmoErIeLK-F5I1oCB_qG_T2pDvH8GcpDvTkkoWxeIWwJC1bIUUtZQGbE2hjSCnCoOfoJhMPmhJ9rEU_1aKPmWsl9FMtmpe92_OBpZugv2ydeyjzN-e5SdaMQ0nKunTBWMMlqWnBPp0wKGHsHUSdbEnRQu9Koln3wf3HyD-E36t8</recordid><startdate>19961201</startdate><enddate>19961201</enddate><creator>Wolff, Dietmar</creator><creator>Skourtopoulos, Menelaos</creator><creator>Hörnschemeyer, Dirk</creator><creator>Wolff, Carsten</creator><creator>Körner, Michael</creator><creator>Körfer, Reiner</creator><creator>Kleesiek, Knut</creator><general>Elsevier GmbH</general><general>Nature Publishing Group</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19961201</creationdate><title>Longitudinal monitoring of latent and active human cytomegalovirus infections in peripheral blood of heart transplant recipients by single-tube nested RT-PCR</title><author>Wolff, Dietmar ; Skourtopoulos, Menelaos ; Hörnschemeyer, Dirk ; Wolff, Carsten ; Körner, Michael ; Körfer, Reiner ; Kleesiek, Knut</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c389t-8f492070882a9d7ca01c4592f148972466641deac1905b19673fc4367456504f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1996</creationdate><topic>Antibodies, Viral - immunology</topic><topic>antiviral therapy</topic><topic>Biological and medical sciences</topic><topic>Cytomegalovirus - immunology</topic><topic>Cytomegalovirus - isolation &amp; purification</topic><topic>Cytomegalovirus - physiology</topic><topic>Cytomegalovirus Infections - blood</topic><topic>Cytomegalovirus Infections - complications</topic><topic>Cytomegalovirus Infections - diagnosis</topic><topic>DNA Primers - genetics</topic><topic>DNA, Complementary - biosynthesis</topic><topic>DNA, Viral - isolation &amp; purification</topic><topic>early diagnosis</topic><topic>ganciclovir</topic><topic>Ganciclovir - therapeutic use</topic><topic>Genes, Viral</topic><topic>Heart Transplantation - adverse effects</topic><topic>Human viral diseases</topic><topic>Humans</topic><topic>Immunocompromised Host</topic><topic>Immunosuppression</topic><topic>Infectious diseases</topic><topic>Longitudinal Studies</topic><topic>Medical sciences</topic><topic>patient management</topic><topic>Polymerase Chain Reaction - methods</topic><topic>RNA, Viral - isolation &amp; purification</topic><topic>Sensitivity and Specificity</topic><topic>Time Factors</topic><topic>trehalose</topic><topic>Viral diseases</topic><topic>Viral diseases of the lymphoid tissue and the blood. Aids</topic><topic>Virus Latency - drug effects</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wolff, Dietmar</creatorcontrib><creatorcontrib>Skourtopoulos, Menelaos</creatorcontrib><creatorcontrib>Hörnschemeyer, Dirk</creatorcontrib><creatorcontrib>Wolff, Carsten</creatorcontrib><creatorcontrib>Körner, Michael</creatorcontrib><creatorcontrib>Körfer, Reiner</creatorcontrib><creatorcontrib>Kleesiek, Knut</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Microbiological research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wolff, Dietmar</au><au>Skourtopoulos, Menelaos</au><au>Hörnschemeyer, Dirk</au><au>Wolff, Carsten</au><au>Körner, Michael</au><au>Körfer, Reiner</au><au>Kleesiek, Knut</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Longitudinal monitoring of latent and active human cytomegalovirus infections in peripheral blood of heart transplant recipients by single-tube nested RT-PCR</atitle><jtitle>Microbiological research</jtitle><addtitle>Microbiol Res</addtitle><date>1996-12-01</date><risdate>1996</risdate><volume>151</volume><issue>4</issue><spage>343</spage><epage>349</epage><pages>343-349</pages><issn>0944-5013</issn><eissn>1618-0623</eissn><abstract>PCR is a sensitive diagnostic tool for the detection of human cytomegalovirus (HCMV) DNA in the peripheral blood of immunosuppressed transplant recipients. However, its specificity as a prognostic marker for clinical disease is unclassified, because infections considered to be latent may be detected by this method. In order to diagnose active viral infections, we used reverse transcription-PCR (RT-PCR) to identify HCMV mRNA in blood. We developed a single-tube nested RT-PCR with preformed PCR mixes embedded in a trehalose matrix. Blood samples of 48 heart transplant recipients were investigated for HCMV DNA. 8 patients detected to be HCMV DNA positive after transplantation were investigated in longitudinal monitoring for at least 6 months. HCMV mRNA was found in 5 patients who developed HCMV related symptoms during the period of RNA detection. There was no clear relation between the onset of DNA detection and the first demonstration of mRNA. In 2 patients HCMV DNA could be detected 74 and 81 days before the appearance of mRNA, suggesting long persistence until active infection is started. In 3 patients HCMV mRNA disappeared during or immediately after the end of ganciclovir therapy. In contrast, HCMV DNA was detectable continuously for prolonged periods after therapy, indicating that the persistance of HCMV DNA is not influenced by ganciclovir treatment. In summary, HCMV mRNA detection seems to be a reliable early marker for the differentiation of persistent and active HCMV infections in immunosuppressed patients. Our data show that viral mRNA detection is probably a better predictor of the effectiveness of antiviral therapy than viral DNA detection.</abstract><cop>Basingstoke</cop><pub>Elsevier GmbH</pub><pmid>9022299</pmid><doi>10.1016/S0944-5013(96)80002-4</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0944-5013
ispartof Microbiological research, 1996-12, Vol.151 (4), p.343-349
issn 0944-5013
1618-0623
language eng
recordid cdi_proquest_miscellaneous_78676377
source MEDLINE; Elsevier ScienceDirect Journals Complete
subjects Antibodies, Viral - immunology
antiviral therapy
Biological and medical sciences
Cytomegalovirus - immunology
Cytomegalovirus - isolation & purification
Cytomegalovirus - physiology
Cytomegalovirus Infections - blood
Cytomegalovirus Infections - complications
Cytomegalovirus Infections - diagnosis
DNA Primers - genetics
DNA, Complementary - biosynthesis
DNA, Viral - isolation & purification
early diagnosis
ganciclovir
Ganciclovir - therapeutic use
Genes, Viral
Heart Transplantation - adverse effects
Human viral diseases
Humans
Immunocompromised Host
Immunosuppression
Infectious diseases
Longitudinal Studies
Medical sciences
patient management
Polymerase Chain Reaction - methods
RNA, Viral - isolation & purification
Sensitivity and Specificity
Time Factors
trehalose
Viral diseases
Viral diseases of the lymphoid tissue and the blood. Aids
Virus Latency - drug effects
title Longitudinal monitoring of latent and active human cytomegalovirus infections in peripheral blood of heart transplant recipients by single-tube nested RT-PCR
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-31T19%3A13%3A05IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Longitudinal%20monitoring%20of%20latent%20and%20active%20human%20cytomegalovirus%20infections%20in%20peripheral%20blood%20of%20heart%20transplant%20recipients%20by%20single-tube%20nested%20RT-PCR&rft.jtitle=Microbiological%20research&rft.au=Wolff,%20Dietmar&rft.date=1996-12-01&rft.volume=151&rft.issue=4&rft.spage=343&rft.epage=349&rft.pages=343-349&rft.issn=0944-5013&rft.eissn=1618-0623&rft_id=info:doi/10.1016/S0944-5013(96)80002-4&rft_dat=%3Cproquest_cross%3E78676377%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=78676377&rft_id=info:pmid/9022299&rft_els_id=S0944501396800024&rfr_iscdi=true